Brainstorm Cell Therapeutics (BCLI)

4.03 -0.02 (0.49%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/16/18 *Est.)

Latest Headlines

Brainstorm Cell Therapeutics (BCLI) Reports First Patient Enrolled in Phase 2 Clinical Trial of Progressive MS March 14, 2019 6:11 AM - StreetInsider BrainStorm Announces First Patient Enrolled in Phase 2 Clinical Trial of Progressive MS March 14, 2019 1:00 AM - Globe NewsWire Form 8-K BRAINSTORM CELL THERAPEU For: Mar 12 March 12, 2019 6:13 AM - SEC Filing Form 4 BRAINSTORM CELL THERAPEU For: Mar 06 Filed by: Kern Ralph Dr. March 8, 2019 5:03 PM - SEC Filing BrainStorm to Host Business Update Conference Call March 7, 2019 4:00 AM - Globe NewsWire Form 4 BRAINSTORM CELL THERAPEU For: Feb 01 Filed by: Polverino Anthony J. February 22, 2019 5:02 PM - SEC Filing Brainstorm Cell Therapeutics (BCLI) Reports First Contracted U.S. Clinical Site for Phase 2 Progressive MS Study February 22, 2019 7:34 AM - StreetInsider BrainStorm Announces First Contracted U.S. Clinical Site for Phase 2 Progressive MS Study February 22, 2019 7:30 AM - Globe NewsWire BrainStorm to Present at 2019 Sachs Associates European Life Sciences CEO Forum in Zurich, Switzerland February 21, 2019 6:01 AM - Globe NewsWire Brainstorm Cell Therapeutics (BCLI) Issues Statement to Patients, Shareholders February 19, 2019 8:14 AM - StreetInsider BrainStorm Issues a Statement to Patients and Shareholders February 19, 2019 8:06 AM - Globe NewsWire BrainStorm to Present at 2019 BIO CEO & Investor Conference and Extracellular Vesicles in Diagnostics & Therapeutics Symposium February 4, 2019 8:22 AM - Globe NewsWire BrainStorm Cell Therapeutics to Present at the 2019 NobleCon15 Annual Investor Conference in Fort Lauderdale, Florida January 25, 2019 7:14 AM - Globe NewsWire BrainStorm Granted Additional Patent for NurOwn® in Israel January 22, 2019 8:40 AM - Globe NewsWire BrainStorm to Present NurOwn® Phase 3 Study Update at the 9th Annual California ALS Research Summit in Irvine, CA January 11, 2019 12:05 AM - Globe NewsWire Form 4 BRAINSTORM CELL THERAPEU For: Jan 04 Filed by: Almenoff June Sherie January 8, 2019 9:01 AM - SEC Filing BrainStorm Cell Therapeutics to Present at the 2019 Biotech Showcase and Sachs Associates Neuroscience Innovation Forum at JPM Week January 3, 2019 6:03 AM - Globe NewsWire Brainstorm Cell Therapeutics (BCLI) Issues Letter to Shareholders December 27, 2018 7:36 AM - StreetInsider BrainStorm Issues 2018 Letter to Shareholders December 27, 2018 7:35 AM - Globe NewsWire Brainstorm Cell Therapeutics (BCLI) Reports Expanded Manufacturing of NurOwn for Phase 2 Progressive MS Trial December 26, 2018 5:44 AM - StreetInsider BrainStorm Expands Manufacturing of NurOwn® for Phase 2 Progressive MS Trial December 26, 2018 1:02 AM - Globe NewsWire Form 4 BRAINSTORM CELL THERAPEU For: Oct 24 Filed by: Schor Chen December 21, 2018 4:36 PM - SEC Filing Form S-8 BRAINSTORM CELL THERAPEU December 21, 2018 4:35 PM - SEC Filing Dawson James Starts Brainstorm Cell Therapeutics (BCLI) at Buy December 18, 2018 12:52 PM - StreetInsider Full Article List